ElevateBio announced the formation of a new company with George Daley, M.D., Ph.D., Dean of Harvard Medical School, and Boston Children’s Hospital, to develop iPSC-derived allogeneic immune therapies. The entity unveiling has been coupled with a Cell Stem Cell publication describing a novel differentiation process from Daley’s lab to develop mature immune cells from induced pluripotent stem cells (iPSCs), a potentially disruptive advantage in the development of allogeneic iPSC-derived immunotherapies . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge